Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.2.2
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of Share-Based Compensation Expense The following table sets forth share-based compensation expense included in general and administrative expense in the condensed consolidated statements of operations:
Three Months Ended September 30,
Nine Months Ended September 30,
(in thousands) (in thousands)
2022 2021 2022 2021
$1,175 $586 $2,954 $1,153
Schedule of Stock Option Activity
Stock option activity under all of the Company’s plans during the nine months ended September 30, 2022 is summarized below:
Stock Options Weighted-average
Exercise price
per share
Weighted-average
Remaining Contractual Life (in years)
Intrinsic
Value(1)
(in thousands)
Outstanding at December 31, 2021 1,350,473  $ 10.10 
Granted 147,723  $ 10.91 
Exercised (29,000) $ 2.36 
Forfeited or expired (69,723) $ 43.24 
Outstanding at September 30, 2022 1,399,473  $ 8.70  6.4 $ 7,251 
(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.
Schedule of Restricted Stock Activity
Restricted stock activity, which includes restricted stock awards ("RSA") and restricted stock unit awards ("RSU"), for the nine months ended September 30, 2022 is summarized below:
Restricted Stock Weighted - Average
Grant
Date Fair Value
Outstanding at December 31, 2021 380,105  $ 10.41 
Granted 471,863  $ 11.10 
Vested (169,666) $ 13.28 
Forfeited (26,941) $ 13.92 
Outstanding at September 30, 2022 655,361  $ 11.27 
Schedule of Common Stock Warrant Activity Common stock warrant activity for the nine months ended September 30, 2022 is as follows:
Warrant
Shares
Weighted-average
Exercise price
per share
Intrinsic
Value(1)
(in thousands)
Outstanding at December 31, 2021 668,907  $ 2.97 
Exercised (462,353) $ 2.20 
Terminated (170,000) $ 2.20 
Outstanding at September 30, 2022
36,554  $ 16.23  $ — 
(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the warrant exercise price of in-the-money warrants.